The third edition of the International Comparative Legal Guide: Drug & Medical Device Litigation, co-authored by Alan E. Rothman, Daniel A. Spira, Amanda M. Blau, and Tanisha Singh is now available. The chapter titled, “Challenges for ex-U.S. Entities Confronting the U.S. Regulatory and Tort Labyrinth” covers personal jurisdiction over ex-U.S. entities, other preliminary forum-related considerations, discovery outside of the U.S., critical and dispositive motions, trial, appeal, enforcement of judgments, and regulatory implications for litigation. This full chapter from the international guide can be viewed below, along with a separate U.S. chapter by the same authors featuring a Q&A on regulatory framework, manufacturing, transactions, advertising, promotion and sales, data privacy, clinical trials and compassionate use programs, product recalls, and dispute resolution.
International Comparative Legal Guide: Drug & Medical Device Litigation 2022
April 21, 2022